Your local 340B hospitals and federally qualified health centers aren’t the villains in this story. They are the safety net.

A program that started in the early nineties meant to help low-income patients, is at the forefront. But some worry that ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

Large hospital networks abuse the federal 340B drug discount program that was intended to boost small care providers. | ...

Discount drug program requires drug companies to sell deeply discounted drugs to hospitals that serve high numbers of low-income patients.

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

Inaccurate information, pushbacks and undue limitations imposed by pharmaceutical manufacturers pose a threat to the 340B ...

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...

For the 5,000 people in Illinois living with sickle cell disease, access to affordable medical care and life-saving ...

Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...

The 340B program was established by Congress in 1992 to provide steep discounts to hospitals that serve a large proportion of ...

WASHINGTON - A Senate health committee met last week to scrutinize the 340B Program, an initiative intended to foster the ...